Laura W. Cheever

3.2k total citations
52 papers, 2.2k citations indexed

About

Laura W. Cheever is a scholar working on Infectious Diseases, Epidemiology and General Health Professions. According to data from OpenAlex, Laura W. Cheever has authored 52 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 34 papers in Epidemiology and 15 papers in General Health Professions. Recurrent topics in Laura W. Cheever's work include HIV/AIDS Research and Interventions (40 papers), HIV, Drug Use, Sexual Risk (27 papers) and HIV-related health complications and treatments (12 papers). Laura W. Cheever is often cited by papers focused on HIV/AIDS Research and Interventions (40 papers), HIV, Drug Use, Sexual Risk (27 papers) and HIV-related health complications and treatments (12 papers). Laura W. Cheever collaborates with scholars based in United States, Qatar and Philippines. Laura W. Cheever's co-authors include Gregory M. Lucas, Richard E. Chaisson, Richard Moore, Richard D. Moore, Kimberly Struble, Thomas F. Kresina, Victoria A. Cargill, Ivan Diamond, Adrienne S. Gordon and Mark Kim and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Neuroscience.

In The Last Decade

Laura W. Cheever

51 papers receiving 2.1k citations

Peers

Laura W. Cheever
Simon Barton United Kingdom
Diana Hartel United States
Ali Judd United Kingdom
Moupali Das United States
Catherine G. Sutcliffe United States
Rebecca A. Clark United States
Erik J.C. van Ameijden Netherlands
Stanley R. Yancovitz United States
Neil M. Flynn United States
David Asboe United Kingdom
Simon Barton United Kingdom
Laura W. Cheever
Citations per year, relative to Laura W. Cheever Laura W. Cheever (= 1×) peers Simon Barton

Countries citing papers authored by Laura W. Cheever

Since Specialization
Citations

This map shows the geographic impact of Laura W. Cheever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura W. Cheever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura W. Cheever more than expected).

Fields of papers citing papers by Laura W. Cheever

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura W. Cheever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura W. Cheever. The network helps show where Laura W. Cheever may publish in the future.

Co-authorship network of co-authors of Laura W. Cheever

This figure shows the co-authorship network connecting the top 25 collaborators of Laura W. Cheever. A scholar is included among the top collaborators of Laura W. Cheever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura W. Cheever. Laura W. Cheever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ledikwe, Jenny H., et al.. (2024). Looking back to see forward: multidirectional learning between the US Ryan White HIV/AIDS Program and the US President’s Emergency Plan for AIDS Relief. BMJ Global Health. 8(Suppl 7). e013953–e013953. 4 indexed citations
2.
Au, Melanie, Andy Jones, Stacy M. Cohen, et al.. (2023). Coordinating Care for People With HIV Who Have Lower Incomes and Alternative Sources of Health Care Coverage. Journal of the Association of Nurses in AIDS Care. 34(3). 280–291.
3.
4.
Fleming, Julia, Stephen A. Berry, Richard D. Moore, et al.. (2019). U.S. Hospitalization rates and reasons stratified by age among persons with HIV 2014–15. AIDS Care. 32(11). 1353–1362. 7 indexed citations
5.
McCree, Donna Hubbard, S. Young, Kirk D. Henny, Laura W. Cheever, & Eugene McCray. (2019). U.S. Centers for Disease Control and Prevention and Health Resources and Services Administration Initiatives to Address Disparate Rates of HIV Infection in the South. AIDS and Behavior. 23(S3). 313–318. 7 indexed citations
6.
Fleming, Julia, W. Christopher Mathews, Richard M. Rutstein, et al.. (2019). Low-level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy. AIDS. 33(13). 2005–2012. 62 indexed citations
7.
Cachay, Edward R., Oluwaseun Falade‐Nwulia, Richard D. Moore, et al.. (2019). HCV Screening and Treatment Uptake Among Patients in HIV Care During 2014–2015. JAIDS Journal of Acquired Immune Deficiency Syndromes. 80(5). 559–567. 10 indexed citations
8.
Raifman, Julia, Keri N. Althoff, Peter F. Rebeiro, et al.. (2018). Human Immunodeficiency Virus (HIV) Viral Suppression After Transition From Having No Healthcare Coverage and Relying on Ryan White HIV/AIDS Program Support to Medicaid or Private Health Insurance. Clinical Infectious Diseases. 69(3). 538–541. 9 indexed citations
9.
Berry, Stephen A., John A. Fleishman, Baligh R. Yehia, et al.. (2016). Healthcare Coverage for HIV Provider Visits Before and After Implementation of the Affordable Care Act. Clinical Infectious Diseases. 63(3). 387–395. 15 indexed citations
10.
Kuhar, David T., David K. Henderson, Kimberly Struble, et al.. (2013). Updated US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Postexposure Prophylaxis. Infection Control and Hospital Epidemiology. 34(9). 875–892. 207 indexed citations
11.
Kresina, Thomas F., et al.. (2012). Substance Abuse Treatment, HIV/AIDS, and the Continuum of Response for People Who Inject Drugs. SHILAP Revista de lepidopterología. 2012. 1–8. 8 indexed citations
12.
Cheever, Laura W., et al.. (2012). Providing HIV Pre-Exposure Prophylaxis. American Journal of Preventive Medicine. 44(1). S147–S150. 2 indexed citations
13.
Cheever, Laura W., et al.. (2011). A Model Federal Collaborative to Increase Patient Access to Buprenorphine Treatment in HIV Primary Care. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(Supplement 1). S3–S6. 27 indexed citations
14.
Rausch, Dianne M., Carl W. Dieffenbach, Laura W. Cheever, & Kevin Fenton. (2011). Towards a More Coordinated Federal Response to Improving HIV Prevention and Sexual Health among Men Who Have Sex with Men. AIDS and Behavior. 15(S1). 107–111. 10 indexed citations
15.
Cheever, Laura W., et al.. (2007). Ensuring Access to Treatment for HIV Infection. Clinical Infectious Diseases. 45(Supplement_4). S266–S274. 19 indexed citations
16.
Edlin, Brian R., Thomas F. Kresina, Daniel Raymond, et al.. (2005). Overcoming Barriers to Prevention, Care, and Treatment of Hepatitis C in Illicit Drug Users. Clinical Infectious Diseases. 40(s5). S276–S285. 167 indexed citations
17.
Kresina, Thomas F., R. Douglas Bruce, Victoria A. Cargill, & Laura W. Cheever. (2005). Integrating Care for Hepatitis C Virus (HCV) and Primary Care for HIV for Injection Drug Users Coinfected with HIV and HCV. Clinical Infectious Diseases. 41(Supplement_1). S83–S88. 19 indexed citations
18.
Kresina, Thomas F., Charles Flexner, Jacqueline F. Sinclair, et al.. (2002). Alcohol Use and HIV Pharmacotherapy. AIDS Research and Human Retroviruses. 18(11). 757–770. 64 indexed citations
19.
Lucas, Gregory M., Laura W. Cheever, Richard E. Chaisson, & Richard Moore. (2001). Detrimental Effects of Continued Illicit Drug Use on the Treatment of HIV-1 Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 27(3). 251–259. 302 indexed citations
20.
Kresina, Thomas F., Laura W. Cheever, Monique Chireau, et al.. (1992). Human EBV-transformed lymphocytes of patients with Schistosoma japonicum infection secrete idiotypically related immunoregulatory antibodies. Clinical Immunology and Immunopathology. 65(3). 325–329. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon Barton Breakdown of academic impact, for papers by Diana Hartel Breakdown of academic impact, for papers by Ali Judd Breakdown of academic impact, for papers by Moupali Das Breakdown of academic impact, for papers by Catherine G. Sutcliffe Breakdown of academic impact, for papers by Rebecca A. Clark Breakdown of academic impact, for papers by Erik J.C. van Ameijden Breakdown of academic impact, for papers by Stanley R. Yancovitz Breakdown of academic impact, for papers by Neil M. Flynn Breakdown of academic impact, for papers by David Asboe
Rankless by CCL
2026